A direct immunofluorescence (IF) method was compared with traditional culture methods for the detection of Actinomyces israelii in endocervical and intra-uterine-device (IUD) smears from 124 IUD wearers. Of 11 specimens that gave positive results by IF, only one was positive by culture. Of the 10 patients with positive IF specimens, three (30%) had signs and symptoms suggestive of pelvic infection and no other pathogen was detected. Direct IF of cervical smears offers a simple, relatively cheap method to screen IUD wearers for A . israelii. Clinical management of such cases is discussed.
Introduction
In the past 20 years, over 400 cases of pelvic actinomycosis have been reported throughout the world, predominantly in association with the wearing of an intra-uterine contraceptive device (IUD). '
Genital actinomycosis is a non-contagious, chronic, suppurative disease which leads to fibrosis and may present as a "frozen pelvis", tubo-ovarian abscess, or with uterine and endometrial involvement. The principal pathogen, Actinomyces israelii, is a fastidious, slowly growing, filamentous, gram-positive anaerobe. Consequently, diagnosis by traditional culture methods from genital swabs is slow, tedious and relatively insensitive. Immunofluorescence (IF) with direct smears of the genital tract provides a rapid method for the identification of A . israelii by morphological and immunological characteristics. ' We report the use of an IF stain of smears, from the endocervices of IUD wearers and from IUDs at removal, in the Royal Women's Hospital, Melbourne, over a 4-month period and discuss the clinical significance and management of patients with a positive smear.
Materials and methods

Pa tien ts
The study group consisted of 124 women with an IUD in situ who attended the Family Planning Clinic (FPC), Gynaecology Clinic or Emergency Department of the Royal Women's Hospital, Melbourne, between Sept. 1988 and Jan. 1989. IUDs included plastic devices such as Lippes Loops and copper-containing devices. The reasons for presentation were : attendance for cessation of contraception, for change of IUD (recommended at the FPC for all copper IUDs after 2 years, or earlier if symptoms occur), for symptoms or signs suggestive of pelvic infection (such as lower abdominal pain, vaginal discharge, altered menses; and lower abdominal or cervical or adnexal tenderness on examination), or for clinical review after previous episodes of infection or, abnormal test results, e.g., cervical cytology reports of the presence of actinomyces-like organisms.
Specimens
The attending medical practitioner placed a cottontipped swab in the endocervix of each patient who presented at the Hospital, and smeared the swab on to two glass slides for staining by Gram's method and IF. Horse-blood agar (HBA) was inoculated with a second endocervical swab, which was then placed into cooked-meat broth; two further swabs, one of them a charcoal swab, were placed into Amies transport medium.
It has been Hospital policy that, before IUD insertion, all patients are screened for Chlamydia trachomatis by wiping away any remaining pus or mucus with a cotton swab, then sampling the endocervix with a cotton-tipped aluminium ENT swab (Medical Wire and Equipment Co., Wilts). Swabs were placed in a sucrose phosphate glutamate transport medium2 supplemented with vancomycin 10 pg/ ml, gentamicin 20 pg/ml, and amphotericin B 10 pg/ ml; they were transported to the laboratory on ice, and were either processed the same day or stored at After removal, IUDs were placed in sterile containers and sent to the laboratory immediately. On arrival, a smear from the IUD was made on a glass slide, for IF staining; it was heat-fixed and stored until tested near the end of the study period.
-70°C.
Bacteriology
One of the cervical smears was stained by Gram's method and examined for polymorphs and organisms. The HBA that had been inoculated with a cervical swab was incubated at 37°C in C 0 2 5-10% for 24 h; and the cooked-meat broth was incubated at 37°C for 24 h before routine subculture for anaerobes. Actinomyces agar3 (modified by the addition of metronidazole 5 pg/ml) was inoculated with the plain cotton swab from Amies medium, and incubated anaerobically at 37°C for 4 weeks; plates were examined weekly, and the identity of likely colonies was confirmed by gram-stain morphology and by gasliquid chromatography. Thayer-Martin medium was inoculated with the charcoal swab in Amies medium for the detection of Neisseria gonorrhoeae.
Swabs from the IUDs were inoculated on to HBA (37"C, C02 5-10%, 24 h), on to supplemented HBA for anaerobic organisms4 (37"C, anaerobically, 48 h) and on to actinomyces agar (37"C, anaerobically, 4 weeks). Bacteria were identified by conventional bacteriological methods;' they included potential pathogens such as Staphylococcus aureus, coliforms, #I-haemolytic streptococci, large numbers of anaerobes and actinomyces. Specimens for C. trachomatis were cultured on HeLa-229 cells in 48-well cluster trays as described previously.6
Immunofluorescence
The method of Pine et aL7 was used with minor modifications. Briefly, heat-fixed smears were digested with pepsin solution (140 U/ml in 0.01 N HC1; Sigma) for 3 h; they were then rinsed and dried, and 20 pl of fluorescein-conjugated antibody to A . israelii types I and I1 (Biological Products Division, Centers for Disease Control, Atlanta, GA, USA) was spread over an area 1-cm square. After incubation at 37°C for 20 min, the slides were thoroughly rinsed, and were counterstained with aqueous Evans Blue 0.5% for 2 min. They were then rinsed, dried, and mounted in phosphate-buffered saline with glycerol, and examined by fluorescence microscopy (Leitz) with 450-490-nm excitor and 5 15-nm suppressor filters.
A control slide, with each IF test, consisted of a negative smear containing cellular material, normal vaginal bacterial flora, and mucus from an actinomyces-free IUD, and positive smears made by mixing material from the same negative IUD with A . israelii type 1 (ATCC 121 03) and type 2 (ATCC 19322) grown in Brewer's thioglycollate medium. Smears of organisms found in the normal vagina (diphtheroids, lactobacilli, streptococci and coliforms), and of Arachnia propionica, were also tested.
IF was graded subjectively from 0 (no detectable cell wall IF) to 4 (the intense fluorescence of the positive control).
Iden t @ca t ion criteria
Slides were considered to be positive for A. israelii if examination revealed more than two microcolonies of filamentous bacteria with evidence of branching and strong IF of the cell wall (grade 3-4). Older positive specimens tended to have a more granular appearance. In most cases, actinomyces microcolonies were embedded in faintly staining amorphous cellular debris, often with large numbers of leucocytes in the smear. Inadequate slides, with no visible cellular material before digestion, were rejected.
Cytology
All patients reviewed at the Hospital clinics were screened for dysplasia or neoplasia, by cervical cytology. Ecto-and endo-cervices were sampled by Ayre spatulae and cytobrushes respectively ; smears were made and fixed immediately, and stained by the method of Papanicolaou.
Results
SpeciJicity of the IF test
No more than a trace of fluorescence (less than grade 1) was observed in smears of vaginal commensal bacteria. Occasionally, fungal hyphae showed weak fluorescence (grade 1-2), but these were readily distinguished from actinomyces by size and other morphological features. Despite previously reported low-level antigenic cross-reactions," a smear of the actinomyces-like organism, Ar. propionica, did not even show grade 1-2 fluorescence.
Detection of actinomyces
A total of 131 specimens (82 cervical and 49 IUD) from 124 patients was examined. Nine (1 1%) of the cervical smears and two (4%) of the IUD smears were positive by IF for A. israelii (table I); these specimens were from 10 patients. Only one specimen was positive by culture, a cervical swab from a patient with an IUD in situ for 18 months, who complained of lower abdominal pain and vaginal discharge ; this patient's cervical smear was also positive by IF. The IUD was removed from three of the 10 patients with a positive cervical smear; in only two of these three was the IUD smear positive by IF. * Both cervical smears and IUDs were received from seven patients.
t The two positive IUDs were from patients with positive cervical smears, though one of the cervical specimens was received outside the 4-month study period.
Symptoms and management of patients
Details of the 10 patients positive for A. israelii are outlined in table 11. IUDs in all these patients had been present for at least 13 months (mean, 29 months). Clinically, three were asymptomatic ; two had minor complaints (discharge with or without lower abdominal pain); three had symptoms and signs suggestive of pelvic inflammation, not in association with other recognised pathogens; two had other pathogens also (chlamydia or trichomonas). In the patient with chlamydia, symptoms were sufficiently severe to require admission to hospital for treatment of pelvic inflammatory disease (PID). Of the asymptomatic patients, two presented for cessation of contraception ; the third (no. 9) came for a routine IUD change, but because of the presence of actinomyces the IUD was removed and an oral contraceptive was prescribed; all three were managed by IUD removal alone. Those with pelvic signs were managed with antibiotics * This specimen was collected outside the study period.
(usually amoxycillin and metronidazole, or metronidazole and doxycycline) and removal of the IUD. In two cases (nos. 4 and 5), antibiotics alone were used initially; however, symptoms persisted until the IUD was removed. No patient had invasive actinomycosis requiring surgical intervention. Ecto-and endo-cervical smears for cytology, taken from seven patients at the same time as cervical smears were taken for actinomyces detection, revealed branching organisms in three (4373, thus predicting the possible presence of actinomyces. Routine microbiological examination of cervical swabs of the 10 positive cases revealed mixed anaerobic organisms, Gardnerella uaginalis, Streptococcus milleri, Str . agalactiae, Haemophilus sp., Escherichia coli and Candida albicans. C. trachomatis also was isolated from one patient (see above).
Discussion
The incidence of PID is reported to be higher in IUD users than in non-users,' although the type of IUD, patient selection, and the presence of sexually transmitted organisms are important factors in assessing the real risk. '-'' In most instances PID is polymicrobial, with various aerobes and anaerobes in addition to sexually transmitted organisms, the commonest of which is C. trachomatis.12 Reports of Actinomyces spp. in cases of PID in IUD wearers have varied from 17% to 25% ;' 39 l4 the most significant risk factor for genital actinomycosis has been long-term usage of an IUD.'59 l 6
The method of choice for the detection of A . israelii in genital specimens'. 149 1 7 * l 8 has been IF. Culture techniques are insensitive because of the oxygensensitive, fastidious and slow-growing nature of the organisms, and difficulty in selecting it from other faster-growing anaerobes' 8-20 found in the normal flora of the genital tract. This has been demonstrated in our study, in which only one patient was positive by culture. Examination of Papanicolaou-stained smears for the presence of actinomyces-like organisms has been shown to be more sensitive than culture, but it still lacks sensitivity and specificity even in the most highly skilled hands. 16* l 7 Furthermore, by morphology alone, it is not possible to distinguish A. israelii from related Actinomyces, Arachnia and Nocardia. In contrast, IF can utilise both morphology and antigenic features. The anti-A. israelii conjugate used in this study, and other similar preparations, have been tested extensively by several authors7' 16* l8 who found this to be the most sensitive and specific method for the detection of A. israelii. Also, this method can be applied directly to histological sections in cases of invasive di~ease.~ Actinomyces is detected frequently in genital smears of asymptomatic IUD wearers. The clinical significance is uncertain, and whether this represents a risk factor for subsequent development of PID is a pertinent question. Where IF has been used in both retrospective and prospective studies, there are two schools of thought. One believes that recognition of actinomyces in a genital smear is always related to a foreign body, most commonly an IUD.139 Although in the majority of such patients infection is confined to the superficial layers of the endometrium, there is potential for more serious disease if the device remains in situ. In contrast, others'. 'y 21, 22 consider actinomyces colonisation in healthy non-IUD users to be part of the normal indigenous vaginal flora. Generally, colonisation rates reported by the latter group were low but the study populations were small (table 111) . In our 4-month study, nine (1 1%) of 82 cervical smears from IUD users were positive for actinomyces; the rate for the whole of 1989 was lo%, of 350 specimens. Three (30%) of our positive patients had significant symptoms, a higher proportion than expected; and three (30%) were asymptomatic. In all seven symptomatic patients, the IUD had been in situ for more than 13 months (mean, 29 months).
With such diversity of opinion, the management of IUD users with actinomyces is somewhat arbitrary, and varies from centre to ~entre.'.'~ 13*149 2',22 For * Multiple genital and perineal sites from each patient were cultured over two menstrual cycles.
t Papanicolaou-stained smears were examined for actinomyces-like organisms. These were not detected in 63 250 smears from women without IUDs; but they were found in 212 of 6450 smears from IUD wearers and, when these 212 were re-examined by IF, 103 were positive.
IUD wearers, we propose that A. israelii be sought by IF of a cervical smear at 2-year intervals, or earlier if symptoms occur. An asymptomatic IUD user with actinomyces should have the device removed, and should use other means of contraception. Alternatively, after 2-3 months, another cervical smear may be examined; if negative for A. israelii, as is usual in our experience, another IUD may be inserted. If the IUD wearer presents with localised symptoms, we recommend antibiotic therapy (amoxycillin and metronidazole, or doxycycline, for 2-3 weeks) and removal of the IUD. Fortunately pelvic actinomycosis is uncommon; but it is a serious and potentially lifethreatening infection. If a pelvic mass is evident,
